Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06628752

Deep Brain Stimulation for Obsessive-compulsive Disorder

Led by Umeå University · Updated on 2024-10-17

26

Participants Needed

1

Research Sites

642 weeks

Total Duration

On this page

Sponsors

U

Umeå University

Lead Sponsor

R

Region Västerbotten

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate the treatment method of deep brain stimulation (DBS) in patients diagnosed with severe and treatment-resistant obsessive-compulsive disorder (OCD). DBS will be administered into the brain area of the bed nucleus of stria terminalis (BNST). The main research questions are: * Does active DBS in BNST reduce OCD symptoms (primary outcome)? * Does active DBS in BNST reduce anxiety or depressive symptoms and improve the level of daily function? The participants will be randomized to active or sham DBS in the BNST for six months and we will measure the outcomes before DBS surgery, and six months post-surgery. After the randomization phase, the participants will enter an open-label phase and receive continuous DBS in BNST. Yearly follow-ups will be conducted. The outcomes will be measured through interviews using validated psychometric scales.

CONDITIONS

Official Title

Deep Brain Stimulation for Obsessive-compulsive Disorder

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • OCD diagnosed according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).
  • At least 16 sessions of cognitive behavioral therapy received.
  • Tried three different serotonergic antidepressants in adequate doses for three months.
  • Tried one serotonergic antidepressant combined with a neuroleptic drug.
  • Severe OCD symptoms with Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 25 or higher.
  • Substantial incapacity due to symptoms.
  • Symptoms present for at least 5 years.
  • Able to understand the consequences of participation and provide informed written consent.
Not Eligible

You will not qualify if you...

  • Unable to understand the consequences of the treatment.
  • Diagnosed with intellectual disability according to DSM-IV.
  • Not meeting the requirements for the neurosurgery procedure.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Umeå University

Umeå, Västerbotten County, Sweden, 90187

Actively Recruiting

Loading map...

Research Team

V

Viktoria Johansson, PhD

CONTACT

M

Matilda Naesstrom, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here